Answers are grounded in this paper and cite their sources.
Photoimmunotherapy (PIT) is a treatment for unresectable locally advanced head and neck cancer or locally recurrent head and neck cancer that has become difficult to treat after standard therapies.PIT was approved in Japan in January 2021.PIT enhances the immune response and, when combined with immune checkpoint inhibitors (ICIs) , its effectiveness is amplified.This study presents two cases where PIT was highly effective after ICI treatment.The first case was a 69-year-old male with oropharyngeal squamous cell carcinoma and the second case was a 66-year-old male with recurrent anterior neck cancer.In both cases, complete response (CR) was maintained after one course of PIT for the residual disease following ICI.The combination of PIT and ICIs showed a synergistic effect.Although there is no consensus on the optimal timing for conducting PIT, these results suggest that PIT following ICI treatment may be a highly effective option.
No takes yet. Share an insight, caveat, or question.
Hayashi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: